
Henry Schein heads into its third-quarter report with an unusual split between what management is saying and what the market is pricing. Three months ago, new CEO Fred Lowery delivered his first guidance raise, pointing to accelerating consumables demand, margin expansion in every segment and a cost program that had finally moved from planning to execution. Since then the shares have fallen 6.6% while the S&P 500 was essentially flat. The quarter due before the open on November 3 is the first in which the promised savings are supposed to show up, which makes it a real test of whether that optimism was earned.
The Street is looking for earnings of $1.34 a share on revenue of $3.47 billion. Sales growth of about 3.9% would be respectable, but earnings are expected to slip 2.9% from last year's $1.38. Much of that decline is optical: the year-ago quarter included a $28 million remeasurement gain that will not recur, and management has already said its full-year remeasurement benefit is capped at $11 million, all booked in the first quarter. Matching last year's per-share figure without that cushion would imply meaningful operating improvement. The whisper number of $1.38 sits modestly above consensus, suggesting some participants expect exactly that.
Management's full-year outlook frames the bar. The company now guides to earnings of $5.29 to $5.39 a share on revenue of $13.78 billion to $13.91 billion. Consensus of $5.32 sits in the lower half of the earnings range, while the $13.72 billion revenue estimate falls below the bottom of management's sales guide. With first-half earnings of $2.59, the guide implies $2.70 to $2.80 in the back half, so a $1.34 third quarter leaves the heavier lift for the fourth. Analysts appear unconvinced that the raised sales trajectory and cost savings will translate into proportional profit dollars, which gives the company room to surprise if execution holds.
The operational checklist comes straight from the last call. U.S. dental merchandise growth jumped to 6.5% in local currency from 4.1%, and investors should want evidence that the improvement was durable rather than a timing blip. Technology accelerated to 9.1%, helped by roughly 13,000 cloud subscribers and record Dentrix Ascend additions carrying higher revenue per user, a mix shift that supports the claim that high-margin businesses now generate about half of operating income. U.S. dental equipment, down 1.1% on tough dental-school comparisons, was expected to resume growth in the second half; a second straight decline would undercut that assurance. Most important, the outsourcing partner's first phase was live with benefits starting this quarter, and the company still targets a $125 million run-rate by the end of 2026. Visible operating-margin expansion beyond the second quarter's 7.21% would validate that timeline.
Risks flagged last time remain live swing factors: soft respiratory diagnostic demand in medical, only modest U.S. premium implant growth compared with Europe, and pricing pressure from cheaper intraoral scanners weighing on digital equipment. A fading currency tailwind could also blunt reported growth.
Sentiment has cooled, with bullish readings roughly halving from the prior quarter, and the stock at $84.96 sits in the lower half of its post-earnings range of $79.37 to $92.18, though still above its 200-day average near $80.85. That combination of improving fundamentals and a skeptical tape sets up a clean verdict. If Henry Schein shows the cost program lifting margins while consumables and software keep compounding, the case for double-digit earnings growth in 2027 strengthens considerably. If savings lag or equipment stays negative, the market's doubts about the raised outlook will look justified.
This earnings preview was originally published on Earnings Whispers.
This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It is AI-assisted, based on proprietary Earnings Whispers data and company reports, and edited by Earnings Whispers staff.
| 30 min | |
| Oct-20 | |
| Oct-09 | |
| Oct-08 | |
| Sep-30 | |
| Sep-08 | |
| Aug-04 | |
| Aug-04 | |
| Aug-03 | |
| Jul-30 | |
| Jul-27 | |
| Jul-21 | |
| Jul-09 | |
| Jul-08 | |
| Jul-06 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite